CAMBRIDGE, Mass., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has approved a new intramuscular (IM) injection route of ...

Credit: FDA. The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, ...

The study underscores Small Pharma's core mission, which is patient access, CEO George Tziras says. The company hopes to be one step closer to understanding the potential efficacy of SPL026 as a ...

A brief history of vaccine routes. 'Depot' effect: How this immunological dogma got started and a brief assessment of its impact. Role practical field conditions play in choice of vaccination routes.

(RTTNews) - Biogen Inc. (BIIB) said that the European Commission has approved a new intramuscular or IM injection route of administration for Plegridy or peginterferon beta-1a for the treatment of ...

Currently, the FDA-approved route of administration of Tysabri for MS is through intravenous infusion. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Biogen ...

Positive opinion also granted for KEYTRUDA as part of a perioperative regimen for the treatment of certain adult patients with resectable locally advanced head and neck squamous cell carcinoma ...